- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 311/51 - Y being a hydrogen or a carbon atom
Patent holdings for IPC class C07C 311/51
Total number of patents in this class: 251
10-year publication summary
16
|
16
|
21
|
23
|
26
|
13
|
16
|
22
|
11
|
4
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
FUJIFILM Corporation | 29228 |
17 |
F. Hoffmann-La Roche AG | 7926 |
10 |
Bristol-myers Squibb Company | 4892 |
6 |
BASF SE | 20777 |
5 |
Board of Regents, The University of Texas System | 5751 |
5 |
Max-delbruck-centrum fur Molekulare Medizin | 50 |
5 |
Navitor Pharmaceuticals, Inc. | 32 |
5 |
The Board of Regents of the University of Texas System | 2199 |
5 |
AstraZeneca AB | 2928 |
4 |
Merck Patent GmbH | 5850 |
4 |
Biogen MA Inc. | 892 |
4 |
Dompé Farmaceutici S.p.A. | 267 |
4 |
EA Pharma Co., Ltd. | 86 |
4 |
Hydro-Quebec | 644 |
4 |
Vivace Therapeutics, Inc. | 30 |
4 |
Novartis AG | 10904 |
3 |
Genentech, Inc. | 3961 |
3 |
Bayer Cropscience AG | 2062 |
3 |
Murata Manufacturing Co., Ltd. | 24342 |
3 |
Shin-Etsu Chemical Co., Ltd. | 5598 |
3 |
Other owners | 150 |